Compare CLDX & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | LWLG |
|---|---|---|
| Founded | N/A | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 1995 | 2011 |
| Metric | CLDX | LWLG |
|---|---|---|
| Price | $29.61 | $10.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $46.60 | N/A |
| AVG Volume (30 Days) | 644.2K | ★ 9.6M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | $236,855.00 |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 87.78 | ★ 147.74 |
| 52 Week Low | $18.56 | $0.92 |
| 52 Week High | $35.83 | $18.71 |
| Indicator | CLDX | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 41.91 |
| Support Level | $28.30 | $10.61 |
| Resistance Level | $30.90 | $18.28 |
| Average True Range (ATR) | 1.52 | 2.15 |
| MACD | -0.48 | -0.74 |
| Stochastic Oscillator | 5.82 | 1.37 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.